ClinicalTrials.govpublic full text
CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies
t-cell acute lymphocytic leukemia, acute lymphoblastic leukemia, in relapse, refractory acute lymphoblastic leukemia, t-cell malignancies
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 363603
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.